The Real COVID Agenda, Getting an HIV Vaccine to Market
Mercola | 5 Aug 2022 STORY AT-A-GLANCE July 25, 2022, Chinese officials granted conditional approval to Azvudine, an HIV drug, to be used as a COVID treatment Use of the HIV drug has reignited interest in early evidence suggesting SARS-CoV-2 is a bioweapon augmented with parts of the HIV virus In late January 2020, Indian…